- £11.30bn
- £13.36bn
- £3.19bn
- 59
- 28
- 92
- 64
2019 December 31st | 2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,890 | 1,661 | 1,583 | 2,262 | 3,190 |
Cost of Revenue | |||||
Gross Profit | 1,909 | 1,134 | 1,053 | 1,484 | 2,066 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 2,461 | 2,711 | 1,437 | 2,068 | 2,680 |
Operating Profit | 429 | -1,051 | 146 | 194 | 510 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 319 | -1,140 | 78.4 | 169 | 492 |
Provision for Income Taxes | |||||
Net Income After Taxes | 229 | -1,032 | 44.3 | 142 | 463 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 226 | -1,042 | 77.9 | 1,632 | 419 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 226 | -1,042 | 77.9 | 1,632 | 419 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.385 | 0.083 | -0.227 | -0.08 | 0.411 |
Dividends per Share |